Overview

Effect of Ginseol Kg1 on Blood Pressure Lowering

Status:
Unknown status
Trial end date:
2012-12-01
Target enrollment:
0
Participant gender:
All
Summary
In this study, we investigate the effects of Ginseol Kg1 (Korea red ginseng extract) on blood pressure in prehypertensive or stage I hypertensive patients.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Seoul National University Hospital
Collaborator:
DongGuk University
Criteria
Inclusion Criteria:

- Age: Adults over 20 years

- Prehypertension or stage 1 hypertension (systolic blood pressure 120~159mmHg or
diastolic blood pressure 80~99mmHg)

- Subject who has not taken medications to treat hypertension within 15 days prior to
first visit

Exclusion Criteria:

- Subject who has been involved in other clinical trials within 30 days prior to first
visit

- Subject who has following diseases within 2 years prior to screening: angina pectoris,
myocardial infarction, heart failure, peripheral vascular disease, chronic liver
failure, chronic renal failure, diabetes mellitus, hyperthyroidism, hypothyroidism,
malignant tumor, mental disease

- Systolic blood pressure ≥ 160mmHg or diastolic blood pressure ≥ 100 mmHg during
screening period

- Subject who has hepatic dysfunction(AST, ALT ≥ 2.5 times higher than normal value)

- Subject who has renal dysfunction(creatinine ≥ 1.5 times higher than normal value)

- Subject who is pregnant or breast feeding

- Alcoholic

- Subject who has an allergy to the ingredients of study product